The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Center for ...

Earlier this week, AstraZeneca announced that the FDA is reviewing an application for its nasal spray flu vaccine FluMist, which would become the first self-administered flu vaccine available ...

Chief scientific officer Scot Roberts said that the COVID-19 vaccine's low immune response was at odds with its earlier trials of an intranasal influenza vaccine NasoVAX, offering this possible ...

View Full Profile. Learn about our Editorial Policies. With rare exceptions like the oral polio vaccine and intranasal vaccines against influenza, the majority of immunizations are administered ...

Our stories are reviewed by medical professionals to ensure you get the most accurate and useful information about your health and wellness. For more information, visit our medical review board.

HKU State Key Laboratory for Emerging Infectious Diseases and InnoHK Centre for Virology, Vaccinology and Therapeutics Successfully Develop Nasal ...

Leyden Laboratories BV added a fresh $70 million in financing to advance Panflu, its phase II-ready intranasal pan-influenza prophylactic medicine, while acquiring Cov Biotechnology Pte. Ltd. (Covbio) ...